Nora Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nora Therapeutics - overview
Established
1992
Location
Palo Alto, CA, US
Primary Industry
Pharmaceuticals
About
Founded in 1992, Nora Therapeutics is a US-based biotechnology company focused on developing innovative therapeutic solutions for conditions requiring advanced treatment options. Nora Therapeutics specializes in biopharmaceuticals, aiming to create effective therapies for various medical conditions. The company was founded in Palo Alto, US, in 1992. It has completed a total of 5 deals since its inception.
The most recent funding round occurred on October 13, 2015, where the company raised USD 1 mn in VENTURE DEBT funding, contributing to a total amount raised of USD 18 mn. Nora Therapeutics plans to leverage the recent funding obtained in October 2015 to support the development of new therapeutic products. While specific products or launch dates have not been disclosed, the company is expected to explore expansion into new geographical regions in the near future.
Current Investors
Burrill & Company, Prospect Venture Partners, Vivo Capital
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.noratherapeutics.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.